August 26th 2025
Innovation, adaptability, and clear communication are key to managing outcomes.
August 20th 2025
Advances address a need for the growing populace with age-related near vision loss.
July 31st 2025
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
July 28th 2025
LENZ Therapeutics previously licensed Greater China rights to CORXEL for the development and commercialization of LNZ100 in April 2022.
July 8th 2025